Plasma Kininogenases and Their Activators
暂无分享,去创建一个
[1] givenName surName,et al. Relation of the fibrinolytic mechanism to other proteolytic systems in plasma , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[2] givenName surName,et al. Enzymic aspects of plasma kinin formation , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[3] P. W. Hemker,et al. H. The Kinetics of Enzyme Cascade Systems General kinetics of enzyme cascades , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[4] C. Kasper,et al. Hageman Factor (Factor XII) in an Affected Kindred and in Normal Adults , 1968, British journal of haematology.
[5] M. Drillings,et al. Inhibition of Hageman factor activation. , 1968, The Journal of clinical investigation.
[6] V. Donaldson. MECHANISMS OF ACTIVATION OF C'1 ESTERASE IN HEREDITARY ANGIONEUROTIC EDEMA PLASMA IN VITRO , 1968, The Journal of experimental medicine.
[7] W. J. Graham,et al. Studies on the evolution of plasma kinins: Reptilian and avian blood , 1967 .
[8] K. Robbins,et al. The specific mechanism of activation of human plasminogen to plasmin. , 1967, The Journal of biological chemistry.
[9] T. Suzuki,et al. Separation of a new substrate, kininogen-I, for plasma kallikrein in bovine plasma. , 1967, Journal of biochemistry.
[10] Kellermeyer Rw. Inflammatory process in acute gouty arthritis. 3. Vascular permeability-enhancing activity in normal human synovial fluid; induction by Hageman factor activators; and inhibition by Hageman factor antiserum. , 1967 .
[11] M. Rocha e Silva,et al. Release of kinins from fresh plasma under varying experimental conditions. , 1967, Biochemical pharmacology.
[12] T. Suzuki,et al. Partial purification of bovine plasma kallikrein activated by contact with glass. , 1967, Journal of biochemistry.
[13] R. Od,et al. Abolition of the permeability-enhancing properties of Hageman factor by specific antiserum. , 1967 .
[14] T. Suzuki,et al. An improved method for the purification of kininogen-II from bovine plasma. , 1967, Journal of biochemistry.
[15] I. Roitt,et al. Antiglobulin factors in sera from patients with rheumatoid arthritis and normal subjects. Quantitative estimation in different immunoglobulin classes. , 1967, Annals of the rheumatic diseases.
[16] K. Robbins,et al. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. , 1967, The Journal of biological chemistry.
[17] K. Melmon,et al. The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies. , 1967, Arthritis and rheumatism.
[18] O. Ratnoff,et al. THE CONVERSION OF C'1S TO C'1 ESTERASE BY PLASMIN AND TRYPSIN , 1967, The Journal of experimental medicine.
[19] A. Rothschild,et al. Sulphuric Esters of Polysaccharides as Activators of a Bradykinin-forming System in Plasma , 1966, Nature.
[20] D. Thomas,et al. Activation of Intravascular Coagulation by Collagen.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[21] V. Donaldson. Serum inhibitor of C'1-esterase in health and disease. , 1966, The Journal of laboratory and clinical medicine.
[22] A. Fletcher,et al. Activity of Plasmin and Streptokinase-Activator on Substituted Arginine and Lysine Esters , 1966, Thrombosis and Haemostasis.
[23] H. L. F. Currey,et al. Significance of Radiological Calcification of Joint Cartilage , 1966, Annals of the rheumatic diseases.
[24] M. E. Webster. The Kallikrein-kininogen-kinin system. , 1966, Arthritis and rheumatism.
[25] L. Greenbaum,et al. The in vitro inactivation and formation of plasma kinins by spleen cathepsins. , 1966, British journal of pharmacology and chemotherapy.
[26] S. Jacobsen,et al. The effect of scalding on the content of kininogen and kininase in limb lymph. , 1966, British journal of pharmacology and chemotherapy.
[27] S. Jacobsen. Observations on the content of kininogen, kallikrein and kininase in lymph from hind limbs of dogs and rabbits. , 1966, British Journal of Pharmacology and Chemotherapy.
[28] H. Nossel. Activation of Factors XII (Hageman) and XI (PTA) by Skin Contact.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[29] G. E. Davies,et al. Inhibitory effects of thiol compounds on kallikrein and on experimental burns in guinea-pigs. , 1966, British journal of pharmacology and chemotherapy.
[30] S. Levine,et al. Enzyme Amplifier Kinetics , 1966, Science.
[31] V. Eisen. Urates and Kinin Formation in Synovial Fluid , 1966, Proceedings of the Royal Society of Medicine.
[32] Kellermeyer Rw,et al. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid. , 1966, The Journal of laboratory and clinical medicine.
[33] B. Zweifach,et al. The inflammatory process , 1966 .
[34] E. Becker,et al. RELEASE OF KALLIKREIN FROM GUINEA PIG LUNG DURING ANAPHYLAXIS , 1966, The Journal of experimental medicine.
[35] S. Jacobsen. Substrates for plasma kinin-forming enzymes in human, dog and rabbit plasmas. , 1966, British journal of pharmacology and chemotherapy.
[36] M. Małofiejew,et al. Activation of Fibrinolysis and of Plasma-Kinin System during Venostasis* , 1965, Thrombosis and Haemostasis.
[37] O. Ratnoff,et al. Hageman Factor: Alterations in Physical Properties during Activation , 1965, Science.
[38] H. Moriya,et al. Biochemical studies on kallikreins and their related substances. 3. Preliminary experiment of studies on human plasma kallikrein. , 1965, Journal of biochemistry.
[39] V. Eisen. Studies on Fibrinogen Fractions Isolated from Human Plasma by Precipitation with Cold Ether , 1965, British journal of haematology.
[40] M. Mackay,et al. Studies on Fibrinogen Fractions Isolated from Human Plasma by Precipitation with Cold Ether , 1965, British Journal of Haematology.
[41] J. Hill,et al. Activated Human Hageman Factor (XII)* , 1965, Thrombosis and Haemostasis.
[42] R. Kellermeyer. Activation of Hageman factor by sodium urate crystals. , 1965, Arthritis and rheumatism.
[43] Brenda Mason,et al. The relationship between the permeability-increasing and the hypotensive proteases of plasma. , 1965, British journal of pharmacology and chemotherapy.
[44] S. Ali,et al. STUDIES ON THE TISSUE ACTIVATOR OF PLASMINOGEN. DISTRIBUTION OF ACTIVATOR AND PROTEOLYTIC ACTIVITY IN THE SUBCELLULAR FRACTIONS OF RABBIT KIDNEY. , 1965, The Biochemical journal.
[45] C. Haanen,et al. Hageman factor, a novel sialoglycoprotein with esterase activity. , 1965, Biochimica et biophysica acta.
[46] D. McConnell,et al. Use of Heparin in Distinguishing Plasma Kallikrein from Pf/dil , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[47] J. Niemetz,et al. A NORMAL INHIBITOR OF THE BLOOD COAGULATION CONTACT REACTION PRODUCT. , 1965, Blood.
[48] D. F. Elliott,et al. Methionyl-lysyl-bradykinin, a new kinin from ox blood. , 1965, The Biochemical journal.
[49] R. Graham,et al. PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ. , 1965 .
[50] D. Mccarty,et al. STUDIES ON THE PATHOGENESIS OF RHEUMATOID JOINT INFLAMMATION. I. THE "R.A. CELL" AND A WORKING HYPOTHESIS. , 1965, Annals of internal medicine.
[51] R. Kellermeyer,et al. THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS. , 1965, The Journal of laboratory and clinical medicine.
[52] Kagen Lj. SOME BIOCHEMICAL AND PHYSICAL PROPERTIES OF THE HUMAN PERMEABILITY GLOBULINS. , 1964 .
[53] E. Habermann,et al. [ON SUBSTRATES AND REACTION PRODUCTS OF THE KININ-PRODUCING ENZYMES TRYPSIN, SERUM- AND PANCREATIC KALLIKREIN AND CROTALUS VENOM]. , 1964, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.
[54] R. Holemans,et al. HAGEMAN FACTOR AND IN VIVO ACTIVATION OF FIBRINOLYSIS. , 1964, The Journal of laboratory and clinical medicine.
[55] G. P. Lewis. PLASMA KININS AND INFLAMMATION. , 1964, Metabolism: clinical and experimental.
[56] G. Mills,et al. A HIGHLY PURIFIED KININ-FORMING ENZYME FROM HUMAN PLASMA. , 1964, Biochemical pharmacology.
[57] N. Alkjaersig. The purification and properties of human plasminogen. , 1964, The Biochemical journal.
[58] E. Davie,et al. Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.
[59] V. Eisen. FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES. , 1964, British medical bulletin.
[60] L. Kagen,et al. THE PERMEABILITY GLOBULINS OF HUMAN SERUM AND THE BIOCHEMICAL MECHANISM OF HEREDITARY ANGIONEUROTIC EDEMA , 1964, Annals of the New York Academy of Sciences.
[61] G. Lewis,et al. PLASMA KININS AND OTHER VASOACTIVE COMPOUNDS IN ACUTE INFLAMMATION , 1964, Annals of the New York Academy of Sciences.
[62] G. Markus,et al. THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. I. FUNCTIONAL PROPERTIES OF THE ACTIVATED ENZYME. , 1964, The Journal of biological chemistry.
[63] A. A. Miles. LARGE MOLECULAR SUBSTANCES AS MEDIATORS OF THE INFLAMMATORY REACTION , 1964, Annals of the New York Academy of Sciences.
[64] P. G. Iatridis,et al. Surface Factor Mechanisms in Relation to Blood Platelets: Evidence that Activated Hageman Factor is Present on the Surface of Platelets* , 1964, Thrombosis and Haemostasis.
[65] A. A. Miles,et al. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR. , 1964, British journal of experimental pathology.
[66] Macfarlane Rg,et al. AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .
[67] O. Ratnoff,et al. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. , 1964, The Journal of laboratory and clinical medicine.
[68] V. Eisen,et al. EFFECT OF HEXADIMETHRINE BROMIDE ON PLASMA KININ FORMATION, HYDROLYSIS OF P-TOSYL-L-ARGININE METHYL ESTER AND FIBRINOLYSIS. , 1964, British journal of pharmacology and chemotherapy.
[69] G. E. Davies,et al. PRESENCE OF KALLIKREIN IN THE γ‐GLOBULIN PERMEABILITY FACTOR OF GUINEA‐PIG SERUM , 1963 .
[70] G. Lewis,et al. Kinin‐forming activity and histamine in lymph after tissue injury , 1963, The Journal of physiology.
[71] O. Ratnoff,et al. THE CLOT-PROMOTING EFFECT OF SOAPS OF LONG-CHAIN SATURATED FATTY ACIDS. , 1963, The Journal of clinical investigation.
[72] J. Margolis,et al. STUDIES ON PLASMA KININS. I. THE COMPOSITION OF KININOGEN COMPLEX. , 1963, The Australian journal of experimental biology and medical science.
[73] J. Leddy,et al. THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM. , 1963, The Journal of clinical investigation.
[74] C. Haanen,et al. Purification of Activated Bovine Hageman Factor , 1963, Thrombosis and Haemostasis.
[75] R. Mibashan,et al. Activation of Hageman Factor (Factor XII) by Long-Chain Saturated Fatty Acids , 1963, Thrombosis and Haemostasis.
[76] W. Connor,et al. Massive thrombosis produced by fatty acid infusion. , 1963, The Journal of clinical investigation.
[77] V. Eisen. Observations on intrinsic kinin‐forming factors in human plasma: the effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation , 1963, The Journal of physiology.
[78] V. Eisen. Kinin formation and fibrinolysis in human plasma , 1963, The Journal of physiology.
[79] G. E. Davies,et al. Guinea Pig Kallikrein System , 1963, Nature.
[80] I. Trautschold,et al. [Recent results in the field of plasma kinins]. , 1963, Klinische Wochenschrift.
[81] J. H. Ferguson,et al. Effect of physical exercise on blood clotting and fibrinolysis. , 1963, Journal of applied physiology.
[82] J. Leddy,et al. Isolation of Two Permeability Globulins from Human Serum , 1963, Nature.
[83] G. Mills,et al. Chemical Characterization of Kinins of Human Plasma , 1963, Nature.
[84] J. Pierce,et al. THE NATURE OF THE KALLIDINS RELEASED FROM HUMAN PLASMA BY KALLIKREINS AND OTHER ENZYMES , 1963, Annals of the New York Academy of Sciences.
[85] E. Habermann. SNAKE VENOMS, KALLIKREINS, AND KININOGEN * , 1963, Annals of the New York Academy of Sciences.
[86] A. Munson,et al. ON THE RELATIONSHIP BETWEEN PLASMIN AND KININ * , 1963, Annals of the New York Academy of Sciences.
[87] J. Margolis. THE INTERRELATIONSHIP OF COAGULATION OF PLASMA AND RELEASE OF PEPTIDES , 1963, Annals of the New York Academy of Sciences.
[88] C. Diniz,et al. A MICROMETHOD FOR DETERMINATION OF BRADYKININOGEN UNDER SEVERAL CONDITIONS * , 1963, Annals of the New York Academy of Sciences.
[89] I. Trautschold,et al. KALLIKREIN, KALLIDIN, KALLIKREIN INHIBITORS , 1963, Annals of the New York Academy of Sciences.
[90] J. Margolis. ACTIVATION OF HAGEMAN FACTOR BY SATURATED FATTY ACIDS , 1962 .
[91] E. Davie,et al. The purification of activated Hageman factor (activated factor XII). , 1962, Biochemistry.
[92] A. A. Miles,et al. Globulin Permeability Factors without Kininogenase Activity , 1962, Nature.
[93] D. Mccarty,et al. ACUTE ARTHRITIS IN MAN AND DOG AFTER INTRASYNOVIAL INJECTION OF SODIUM URATE CRYSTALS , 1962 .
[94] M. Mackay,et al. Activation of Endogenous Plasma Proteolytic Enzymes with the Consequent Production of Pharmacologically Active Polypeptides , 1962, Nature.
[95] S. Niewiarowski,et al. Arginine Esterase Activity of the Contact (Hageman) Factor , 1962, Thrombosis and Haemostasis.
[96] E. Erdos,et al. An enzyme in human blood plasma that inactivates bradykinin and kallidins. , 1962, Biochemical pharmacology.
[97] E. Habermann. [Differentiation between kallikrein and kallikrein elements by means of antiserum and diisopropylfluorophosphate]. , 1962, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[98] S. G. Iatridis,et al. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system. , 1962, The Journal of clinical investigation.
[99] W. Connor,et al. THE ACCELERATION OF THROMBUS FORMATION BY CERTAIN FATTY ACIDS. , 1962, The Journal of clinical investigation.
[100] Steinberg Ag,et al. Further studies on the inheritance of Hageman trait. , 1962 .
[101] J. Margolis,et al. Interrelations Between Different Mechanisms of Release of Biologically Active Peptides from Blood Plasma , 1962, Nature.
[102] O. Ratnoff,et al. THE ENHANCEMENT OF CHLOROFORM-INDUCED PLASMA PROTEOLYTIC ACTIVITY BY EPSILON AMINOCAPROIC ACID , 1962, The Journal of experimental medicine.
[103] M. Derechin. Purification of human plasminogen. , 1962, The Biochemical journal.
[104] A. Robb-smith,et al. Functions of the Blood , 1962 .
[105] S. G. Iatridis,et al. Effect of Surface and Hageman Factor on the Endogenous or Spontaneous Activation of the Fibrinolytic System , 1961, Thrombosis and Haemostasis.
[106] G. Palade,et al. STUDIES ON INFLAMMATION , 1961, The Journal of biophysical and biochemical cytology.
[107] N. Back,et al. Distribution and Fate of I131‐Labeled Components of the Fibrinolysin System , 1961, Circulation research.
[108] O. Ratnoff,et al. Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma , 1961, Nature.
[109] C. Haanen,et al. Some Observations on the Rôle of Hageman Factor in Blood Coagulation , 1961, Thrombosis and Haemostasis.
[110] I. Trautschold,et al. [Spectrophotometric determination of kallikrein and its inactivators]. , 1961, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[111] J. Margolis. The effect of colloidal silica on blood coagulation. , 1961, The Australian journal of experimental biology and medical science.
[112] J. Pensky,et al. Partial purification of a serum inhibitor of C'1-esterase. , 1961, The Journal of biological chemistry.
[113] O. Ratnoff,et al. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. , 1961, The Journal of clinical investigation.
[114] J. Pierce,et al. Action of the Kallikreins on Synthetic Ester Substrates , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[115] W. Sawyer. Polypeptides which Affect Smooth Muscles and Blood Vessels: (A Symposium), M. Schachter, M.D., Sc.D., University College, London, Editor. 336 + xv pages, illustrated. New York, Pergamon Press, Inc., 1960. $8.50 , 1961 .
[116] H. Kunkel,et al. Isolation of a Thermolabile Serum Protein which Precipitates γ-Globulin Aggregates and Participates in Immune Hemolysis.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[117] W. Connor. New Blood Clotting Factors , 1961 .
[118] W. Connor,et al. The effect of fatty acids on the formation of thrombi. , 1961, Quarterly journal of experimental physiology and cognate medical sciences.
[119] J. Pierce,et al. Studies on plasma kallikrein and its relationship to plasmin. , 1960, The Journal of pharmacology and experimental therapeutics.
[120] S. Rapaport,et al. Separation of Plasma Thromboplastin Antecedent (PTA) and Hageman Factor (HF) from Human Plasma.∗ , 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[121] G. P. Lewis. Active polypeptides derived from plasma proteins. , 1960, Physiological reviews.
[122] G. E. Davies,et al. A permeability factor released from guinea-pig serum by antigen-antibody precipitates. , 1960, British journal of experimental pathology.
[123] C. Owen,et al. Laboratory and genetic observations in another family with the Hageman trait. , 1960, Proceedings of the staff meetings. Mayo Clinic.
[124] H. D. Anderson,et al. The Preparation of Human Fibrinolysin (Plasmin) * , 1960, Vox sanguinis.
[125] Harold C. Mack,et al. THE PLASMA PROTEINS , 1960 .
[126] K. Bhoola,et al. The effect of bradykinin, serum kallikrein and other endogenous substances on capillary permeability in the guinea‐pig , 1960, The Journal of physiology.
[127] J. Margolis. The mode of action of Hageman factor in the release of plasma kinin , 1960, The Journal of physiology.
[128] M. Davies,et al. Physical properties of highly purified human plasminogen. , 1960, The Journal of biological chemistry.
[129] S. Plotkin. Immunity and Virus Infection , 1960, Pediatrics.
[130] D. Hubbard,et al. Ionic charges of glass surfaces and other materials, and their possible role in the coagulation of blood. , 1960, Journal of applied physiology.
[131] J. Soulier,et al. New Data on Hageman Factor and Plasma Thromboplastin Antecedent: The Role of ‘Contact’ in the Initial Phase of Blood Coagulation , 1960 .
[132] E. Horton,et al. A comparison of the plasma kinin forming enzymes in urine; kallikrein and urokinase , 1959, The Journal of physiology.
[133] U. Hamberg. Fibrinolytic activation and bradykinin release. , 1959, Biochimica et biophysica acta.
[134] K. Ishizaka,et al. Biological Activities of Aggregated Gamma Globulin I. Skin Reactive and Complement-Fixing Properties of Heat Denatured Gamma Globulin.∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[135] J. Margolis. Hagerman factor and capillary permeability. , 1959, The Australian journal of experimental biology and medical science.
[136] A. A. Miles,et al. Enzymic Nature of the Serum Globulin Permeability Factor , 1959, Nature.
[137] A. Fletcher,et al. xi-Aminocaproic acid: an inhibitor of plasminogen activation. , 1959, The Journal of biological chemistry.
[138] A. Fletcher,et al. Fibrinolysis and fibrinolytic activity in man. , 1959, Physiological reviews.
[139] J. Margolis,et al. The Role of Hageman Factor in the Initiation of Blood Coagulation , 1959, British journal of haematology.
[140] J. Margolis,et al. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation , 1958, The Journal of physiology.
[141] O D RATNOFF,et al. Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. , 1958, The American journal of medicine.
[142] P. Mill,et al. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. VI. Isolation and properties of permeability factor and its inhibitor in human plasma. , 1958, British journal of experimental pathology.
[143] D. L. Wilhelm,et al. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. V. Activable permeability factor in human serum. , 1958, British journal of experimental pathology.
[144] P. Norman. STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA , 1958 .
[145] S. Sherry,et al. Physicochemical studies on human plasminogen (profibrinolysin) and plasmin (fibrinolysin). , 1958, The Journal of biological chemistry.
[146] P. Mill,et al. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. IV. Activable permeability factor and its inhibitor in the serum of the rat and the rabbit. , 1958, British journal of experimental pathology.
[147] R. Biggs,et al. Defects in the Early Stages of Blood Coagulation: A Report of Four Cases , 1958, British journal of haematology.
[148] G. Lewis,et al. Formation of plasma kinins by plasmin , 1958, The Journal of physiology.
[149] G. Fearnley,et al. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. , 1957, Clinical science.
[150] J. O'Brien. The effect of some fatty acids and phospholipids on blood coagulation. , 1957, British journal of experimental pathology.
[151] P. Mill,et al. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. III. Further observations on the permeability factor and its inhibitor in guinea-pig serum. , 1957, British journal of experimental pathology.
[152] P. B. Stewart,et al. The permeability-increasing factor in diluted human plasma. , 1957, British journal of experimental pathology.
[153] W. Spector. Activation of a globulin system controlling capillary permeability in inflammation , 1957 .
[154] J. Margolis. Initiation of blood coagulation by glass and related surfaces , 1957, The Journal of physiology.
[155] Pilkington Tr. The effect of fatty acids and detergents on the calcium clotting time of human plasma. , 1957 .
[156] C. Keele,et al. Pain‐producing substance in human inflammatory exudates and plasma , 1957, The Journal of physiology.
[157] T. Work,et al. Formation of bradykinin or bradykinin-like substances by the action of plasmin on plasma proteins. , 1957, The Journal of physiology.
[158] W. Spector. The mediation of altered capillary permeability in acute inflammation , 1956 .
[159] T. Astrup,et al. The biological significance of fibrinolysis. , 1956, Lancet.
[160] O. Ratnoff,et al. Observations on the hereditary nature of Hageman trait. , 1956, Blood.
[161] M. Schachter. A delayed slow contracting effect of serum and plasma due to the release of a substance resembling kallidin and bradykinin. , 1956, British journal of pharmacology and chemotherapy.
[162] J. Poole. The effect of certain fatty acids on the coagulation of plasma in vitro. , 1955, British journal of experimental pathology.
[163] O. Ratnoff,et al. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.
[164] A. A. Miles,et al. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. , 1955, British journal of experimental pathology.
[165] A. A. Miles,et al. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor. , 1955, British journal of experimental pathology.
[166] C. Keele,et al. Development of Pain-producing Substance in Human Plasma , 1954, Nature.
[167] H. Broida,et al. Effects of Plastic and Steel Surfaces on Clotting Time of Human Blood.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[168] O. Ratnoff,et al. The multiplicity of plasmin inhibitors in human serum, demonstrated by the effect of primary amino compounds. , 1954, Bulletin of the Johns Hopkins Hospital.
[169] A. A. Miles,et al. Susceptibility of the Guinea Pig to Pharmacological Factors from its Own Serum , 1953, Nature.
[170] M. Dixon. The effect of pH on the affinities of enzymes for substrates and inhibitors. , 1953, The Biochemical journal.
[171] A. A. Miles,et al. Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigs , 1952, The Journal of physiology.
[172] T. Astrup,et al. The fibrin plate method for estimating fibrinolytic activity. , 1952, Archives of biochemistry and biophysics.
[173] Beraldo Wt. Formation of bradykinin in anaphylactic and peptone shock. , 1950 .
[174] P. Cohen,et al. Partial purification and properties of a proteolytic enzyme of human serum. , 1949, The Journal of biological chemistry.
[175] R. G. Macfarlane,et al. Fibrinolysis; its mechanism and significance. , 1948, Blood.
[176] C. Lack. Staphylokinase: an Activator of Plasma Protease , 1948, Nature.
[177] M. Kunitz. CRYSTALLINE SOYBEAN TRYPSIN INHIBITOR , 1947, The Journal of general physiology.
[178] J. Pilling,et al. Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood. , 1946, Lancet.
[179] R. A. Kekwick,et al. Fractionation of Human Plasma with Ether , 1946, Nature.
[180] J. B. Duguid. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. , 1946, The Journal of pathology and bacteriology.
[181] M. Kunitz. CRYSTALLINE SOYBEAN TRYPSIN INHIBITOR , 1946, The Journal of general physiology.
[182] E. Werle,et al. Der Kallikreingehalt des Harns, des Speichels und des Blutes bei Gesunden und Kranken , 1938 .
[183] R. Macfarlane. FIBRINOLYSIS FOLLOWING OPERATION , 1937 .
[184] [Rheumatoid factor]. , 1972, Polskie Archiwum Medycyny Wewnetrznej.
[185] V. Eisen. Kinin formation in human diseases. , 1969, The Scientific basis of medicine annual reviews.
[186] M. Esnouf,et al. Enzymology and the blood clotting mechanism. , 1968, Advances in enzymology and related areas of molecular biology.
[187] I. Miwa,et al. Effect of endotoxin shock on the plasma kallikrein-kinin system of the rabbit. , 1968, Federation proceedings.
[188] N. Back,et al. Effect of inhibitors on kinin-releasing activity of proteases. , 1968, Federation proceedings.
[189] Webster Me. Human plasma kallikrein, its activation and pathological role. , 1968 .
[190] Pierce Jv. Structural features of plasma kinins and kininogens. , 1968 .
[191] H. Kraut,et al. Das Kallikrein-Kinin-System und Seine Inhibitororen , 1968 .
[192] G. E. Davies,et al. Role of hageman factor in the activation of guinea-pig pre-kallikrein. , 1967, British journal of pharmacology and chemotherapy.
[193] E. Werle,et al. Über kininliefernde Peptide aus pepsinverdauten Rinderplasmaproteinen , 1967 .
[194] E. Habermann. Enzymatic Kinin Release from Kininogen and from Low-Molecular Compounds , 1966 .
[195] R. Od,et al. The biology and pathology of the initial stages of blood coagulation. , 1966 .
[196] T. Astrup. Tissue activators of plasminogen. , 1966, Federation proceedings.
[197] N. Back. Fibrinolysin system and vasoactive kinins. , 1966, Federation proceedings.
[198] J. Pierce,et al. The Purification and Some Properties of Two Different Kallidinogens from Human Plasma , 1966 .
[199] J. Margolis. Quantitative Studies of Kinin-Releasing Enzymes in Plasma , 1966 .
[200] C. Keele,et al. Possible Modes of Kinin Formation in Some Pathological States in Man , 1966 .
[201] R. G. Macfarlane. The Basis of the Cascade Hypothesis of Blood Clotting , 1966, Thrombosis and Haemostasis.
[202] Z. Picarelli,et al. Plasma enzymes that release kinins. , 1966, Biochemical pharmacology.
[203] E. Werle,et al. Natürliche Proteinasen-Inhibitoren , 1966 .
[204] D. Kline. Chemistry and biochemistry of the fibrinolytic system. , 1966, Federation proceedings.
[205] W. Vogt,et al. Demonstration of the Presence of Two Separate Kinin-Forming Systems in Human and Other Plasma , 1966 .
[206] A. Fletcher,et al. Observations on the spontaneous arginine and lysine esterase activity of human plasma, and their relation to Hageman factor. , 1966, Thrombosis et diathesis haemorrhagica. Supplementum.
[207] G. Barlow,et al. FURTHER STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN AND PLASMIN. , 1965, The Journal of biological chemistry.
[208] N. Back,et al. ACTIVATION OF BOVINE BRADYKININOGEN BY HUMAN PLASMIN. , 1965, Life sciences.
[209] R. Macfarlane. CHAPTER 13 – Hemostatic Mechanisms in Tissue Injury , 1965 .
[210] I. Innerfield,et al. Interrelationship of human plasma kallikrein and plasmin in inflammation. , 1965, Enzymologia biologica et clinica.
[211] D. Kline. BLOOD COAGULATION: REACTIONS LEADING TO PROTHROMBIN ACTIVATION. , 1965, Annual review of physiology.
[212] Johnston Cl,et al. A study of capillary permeability and its possible relationship to clotting factor XII. , 1965 .
[213] C. Keele,et al. Substances producing pain and itch , 1964 .
[214] H. Nossel. The Contact Phase of Blood Coagulation , 1964 .
[215] W. Vogt. Kinin formation by plasmin, an indirect process mediated by activation of kallikrein , 1964, The Journal of physiology.
[216] L. Vroman. Effects of Hydrophobie Surfaces upon Blood Coagulation , 1963, Thrombosis and Haemostasis.
[217] E. Habermann,et al. PARTIAL PURIFICATION AND PROPERTIES OF A KININOGEN FROM BOVINE BLOOD , 1963 .
[218] G. E. Davies,et al. Further Studies on a Permeability Factor Released from Guinea-Pig Serum by Antigen-Antibody Precipitates: Relationship to Serum Complement , 1962 .
[219] A. Stoessl,et al. PHOTOCHEMICAL SYNTHESES: 2. THE IRRADIATION OF ACENAPHTHENE WITH BENZIL , 1962 .
[220] E. Ronwin. Properties of human plasmin. , 1962, Canadian journal of biochemistry and physiology.
[221] E. Ronwin. The active center of human plasmin. , 1962, Canadian journal of biochemistry and physiology.
[222] A. Hensen,et al. Coagulation Studies in a Case of Hageman Trait , 1961, Thrombosis and Haemostasis.
[223] C. Haanen,et al. A Case of Hageman-Factor Deficiency and a Method to Purify the Factor , 1961, Thrombosis and Haemostasis.
[224] R. Macfarlane. Chapter 14 – The Blood Coagulation System , 1960 .
[225] A. Hansen,et al. The acute phase protein reaction I. C-reactive protein. , 1959, Scandinavian journal of clinical and laboratory investigation.
[226] Waaler Ba. Contact activation in the intrinsic blood clotting system; studies on a plasma product formed on contact with glass and similar surfaces. , 1959 .
[227] Miles Aa. Mediators of the vascular phenomena of inflammation. , 1958 .
[228] T. Paskhina. Homologous serum proteins and their role in phenomena of increased capillary permeability in inflammation. , 1956, Clinica chimica acta; international journal of clinical chemistry.
[229] K. Laidler. Some kinetic and mechanistic aspects of hydrolytic enzyme action , 1955 .
[230] R. A. Kekwick,et al. The separation of protein fractions from human plasma with ether. , 1954, Special report series (Medical Research Council (Great Britain)).
[231] D. Mittelman,et al. A System for the Separation of the Components of Human Blood: Quantitative Procedures for the Separation of the Protein Components of Human Plasma1a,b,c , 1950 .
[232] J. Flynn. Blood clotting and allied problems : transactions of the Fifth Conference February 16-17, 1948, New York , 1948 .
[233] H. Kraut,et al. Über den Nachweis und das Vorkommen des Kallikreins im Blut. VIII. Mitteilung über Kallikrein. , 1933 .
[234] H. Kraut,et al. Über ein neues Kreislaufhormon. II. Mitteilung. , 1928 .
[235] J. Roskam. Contribution A L'étude De La Physiologie Normale Et Pathologique Du Globulin , 1923 .
[236] J. Bordet,et al. Recherches sur la coagulation du sang et les sérums anticoagulants , 1901 .
[237] W. D. Halliburton. On the coagulation of the blood , 1888, Proceedings of the Royal Society of London.